Trial intelligence / Profile preview

Lipitor Impact on Aerobic Exercise Adaptations

NCT03360916Phase 4Completed

Sponsor
University of Kansas Medical Center
Start
Feb 2018
Primary completion
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atorvastatin in hypercholesterolemia, sponsored by University of Kansas Medical Center. Started Feb 2018; status: completed.

02

Drugs

atorvastatin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT03360916.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03360916.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call